Summary
Several β-adrenoceptor-blocking agents have been shown to possess free radical scavenging properties. Therefore, the direct cardioprotective properties of propranolol or pindolol were investigated in comparison to superoxide dismutase (SOD). We used isolated rabbit hearts paced at a constant rate (Langendorff, constant pressure: 70 cm H2O, Tyrode solution, Ca2+ 1.8 mmol/l). Acute regional myocardial ischemia (MI) was induced by left coronary artery branch occlusion and quantitated from epicardial NADH-fluorescence photography. Propranolol (10−8 mol/l), pindolol (10−6 mol/l) or SOD (48 I.U./ml) had no significant influence on left ventricular pressure, pressure-rate product or global coronary flow (p > 0.05). Whereas epicardial NADH-fluorescence area after repetitive coronary occlusions was significantly diminished by SOD-treatment (−25%) (p < 0.05), MI size was not significantly affected by either propranolol or pindolol (p > 0.05). Conclusion: Oxygen-derived free radicals contribute to tissue injury during myocardial ischemia, and propranolol or pindolol do not possess free radical scavenging properties relevant for cardioprotection in a repetitive coronary occlusion model in isolated rabbit hearts.
Similar content being viewed by others
References
Baller D, Bretschneider HJ, Hellige G (1979) Validity of myocardial oxygen consumption parameters. Clin Cardiol 2:317–327
Baller D, Wolpers HG, Hoeft A, Korb H, Rösick A, Hellige G, Bretschneider HJ (1984) Increase of myocardial oxygen consumption due to active diastolic wall tension. Basic Res Cardiol 76:176–185
Barlow CH, Harken AD, Chance B (1977) Evaluation of cardiac ischemia by NADH fluorescence photography. Ann Surg 186: 737–740
Beta-blocker Heart Attack Trial Research Group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707–1714
Braunwald E (1971) Control of myocardial oxygen consumption. Am J Cardiol 27:416–432
Chance B, Salkovitz JA, Kovach AGB (1972) Kinetiks of mitochondrial flavoprotein and pyridine nucleotide in perfused heart. Am J Physiol 223:207–218
Feild BJ, Russel RO Jr, Dowling JT, Rackley CE (1972) Regional left ventricular performance in the year following myocardial infarction. Circulation 46:679–689
Ferrari R, Ceconi C, Curello S, Ghielmi S, Albertini A (1989) Superoxide dismutase: Possible therapeutic use in cardiovascular disease. Pharmacol Res 21 [Suppl 2]:57–65
Fitzgerald JD (1980) Propranolol. In: Scriabine A (ed) Pharmacology of antihypertensive drugs. Raven Press, New York, pp 195–208
Garlick PB, Davies MJ, Hearse DJ, Slater TF (1987) Direct deletion of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 61:757–760
Herlitz J, Emanuelsson H, Swedberg K, Vedin A, Waldenström A, Waldenström J, Hjalmarson A (1984a) Goteborg metoprolol trial: enzyme-estimated infarct size. Am J Cardiol 53:15D–21D
Herlitz J, Hartford M, Pennert K, Waagstein F, Waldenström A, Wedel H, Wilhelmsson C, Hjalmarson A (1984b) Göteborg metoprolol trial: Clinical observations. Am J Cardiol 53:37D–45D
Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldentröm J, Wedel H, Wilhelmsen L, Wilhelmsson C (1981) Effect of mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet II:823–827
Jentzer JH, Lejemtel TH, Sonnenblick EH, Kirk ES (1981) Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol 48:75–83
Klaus W, Horneff G, Rosen R (1989) The influence of nifedipine on three dimensional distribution of ATP in regional ischemic rabbit hearts. J Mol Cell Cardiol 21[Suppl II]:152
Kloner RA, Przyklenk K, Whittaker P (1989) Deleterious effects of oxygen radicals in ischemia/reperfusion. Circulation 80:1115–1127
Langendorff O (1895) Untersuchungen am überlebenden Süugetierherzen. Pflügers Arch Ges Physiol 61:291–332
Leenen FHH (1976) Assessment of β-adrenoceptor blocking agents in man. In: Saxena PR, Forsyth RP (eds) Beta-adrenoceptorblocking agents. North-Holland Publishing Company, Amsterdem, pp 99–121
Mak IT, Weglicki WB (1988) Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 63:262–266
Mak IT, Arroyo CM, Weglicki WB (1989) Inhibition of sarcolemmal carbon-centered free radical formation by propranolol. Circ Res 65:1151–1156
The MIAMI Trial Research Group (1985) Metoprolol in acute myorcardial infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J 6:199–226
Norris RM, Sammel NL, Clarke ED, Smith WM, Williams B (1978) Protective effect of propranolol in threatened myocardial infarction. Lancet 11:907–909
Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801–807
Pelides LJ, Reid DS, Thomas M, Shillingford JP (1972) Inhibition by betablockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res 6:295–301
Reimer KA, Lowe JE, Rasmussen MM, Jennings RB (1977) The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size versus duration of coronary occlusion in dogs. Circulation 56:786–793
Roberts R, Husain AH, Ambos HD, Oliver GC, Cox JR Jr, Sobel BE (1975) The relationship between infarct size and ventricular arrhythmia. Br Heart J 37:1169–1175
Roesen R, Panzner B, Klaus W (1985) Epicardial image analysis using a desk top computer. Adv Myocardial 6:217–231
Rump AFE, Rösen R, Korth A, Klaus W (1993 a) Deleterious effect of exogenous angiotensin-I on the extent of regional ischaemia and its inhibition by captopril. Eur Heart J 14:106–112
Rump AFE, Rösen R, Klaus W (1993 b) Cardioprotection by superoxide dismutase: A catecholamine-dependent process? Anesth Analg 76:239–246
Rump AFE, Picke D, Rösen R, Klaus W (1993 c) Effects of propranolol, pindolol and carteolol on acute regional myocardial ischemia in isolated rabbit hearts. Arzneim Forsch/Drug Res 43:641–645
Simpson PJ, Lucchesi BR (1987) Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 110:13–30
Surewic WK, Leyko W (1981) Interaction of propranolol with model phospholipid membranes. Biochim Biophys Acta 643:387–397
Williamson JR (1966) Glycolytic control mechanisms. II. Kinetiks of intermediate changes during aerobic-anoxic transition in the perfused rat heart. J Biol Chem 241:5026–5036
Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260:2088–2093
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rump, A.F.E., Rösen, R. & Klaus, W. Free radical scavenging properties of β-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts. Naunyn-Schmiedeberg's Arch Pharmacol 348, 431–434 (1993). https://doi.org/10.1007/BF00171344
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171344